|
**Overview**: Lead Poisoning Panel**Introduction**: The Lead Poisoning Panel is a diagnostic tool designed to assess lead exposure using whole blood samples. In India, childhood lead poisoning affects ~10-20 percent of urban slum children and rural areas near battery recycling or mining, with blood lead levels >5 μg/dL linked to neurodevelopmental delay, anemia, and renal damage. High morbidity from under-testing in rural/low-SES children with unexplained anemia or developmental issues, limited toxicology labs, delayed chelation (succimer) leading to irreversible cognitive impairment. Per pediatrics practices aligned with ICMR and National Programme for Prevention and Control of Fluorosis, Endemic Skeletal Fluorosis and Lead Poisoning guidelines, the test employs spectrophotometry for blood lead level and zinc protoporphyrin over 1-2 days with high accuracy, valuable for screening high-risk children. This diagnostic falls under toxic exposure screening and targets children with pica, anemia, or environmental exposure, addressing accurate detection to guide environmental intervention and chelation. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise lead burden assessment and reducing neurotoxicity burden. Its whole blood-based approach ensures reliable exposure measurement.**Other Names**: Lead Poison Pnl.**FDA Status**: FDA approved, CLIA certified for biochemistry, compliant with 2025 standards.**Historical Milestone**: Blood lead testing standard; in India, expanded under environmental health programs.**Purpose**: The test assesses 2 parameters including blood lead level to guide lead poisoning evaluation, detect exposure, inform chelation.**Test Parameters**: 1. Blood Lead Level, 2. Zinc Protoporphyrin.**Pretest Condition**: No fasting required; patients should report environmental exposure or anemia.**Specimen**: 3 mL whole blood in 1 EDTA tube, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 48 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: Not applicable (fresh sample preferred for analysis).**Medical History**: Patients should provide details on pica, living near industry, developmental delay.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of untreated lead poisoning including neurotoxicity, benefits of screening, and minimal discomfort from blood draw.**Procedural Considerations**: The test involves sample processing using spectrophotometry by trained personnel to ensure sterile technique, avoid contamination, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, or hemolysis can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Elevated blood lead (>5 μg/dL) indicates poisoning, necessitating specialist input.**Specialist Consultation**: Pediatricians or toxicologists should be consulted for management.**Additional Supporting Tests**: Environmental lead testing for confirmation.**Test Limitations**: Reflects recent exposure; comprehensive approach required.**References**: Indian Journal of Pediatrics 2024, Toxicology Studies India 2023. |
